XXE5X38 Measurement of Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction, New Technology Group 8

BackXXE0X07Measurement of Intracranial Vascular Activity, Computer-aided Assessment, New Technology Group 7XXE0X1AMeasurement of Intracranial Cerebrospinal Fluid Flow, Computer-aided Triage and Notification, New Technology Group 10XXE0X48Measurement of Brain Electrical Activity, Computer-aided Semiologic Analysis, New Technology Group 8XXE2X19Measurement of Cardiac Output, Computer-aided Assessment, New Technology Group 9XXE3X27Measurement of Pulmonary Artery Flow, Computer-aided Triage and Notification, New Technology Group 7XXE3X58Measurement of Coronary Artery Flow, Quantitative Flow Ratio Analysis, New Technology Group 8XXE3X68Measurement of Coronary Artery Flow, Computer-aided Valve Modeling and Notification, New Technology Group 8XXE5X2AMeasurement of Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum, New Technology Group 10XXE5X38Measurement of Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction, New Technology Group 8XXE5X4AMeasurement of Infection, Positive Blood Culture Small Molecule Sensor Array Technology, New Technology Group 10XXE5X5AMeasurement of Immune Response, Whole Blood Cellular Assessment via Microfluidic Deformability, New Technology Group 10XXE5XBBMeasurement of Infection and Immune Response, Gene Expression Testing System, New Technology Group 11XXE5XR7Measurement of Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative Pressure, New Technology Group 7XXE5XT7Measurement of Intracranial Arterial Flow, Whole Blood mRNA, New Technology Group 7XXE5XV7Measurement of Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection, New Technology Group 7XXE5XY9Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9XXE97U7Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7XXEZXABMeasurement of Macronutrient Content, Computer-aided Assessment for Nutrition Management, New Technology Group 11XXEZXCBMeasurement of Infection, Computer-aided Triage and Notification, New Technology Group 11
Procedure codeCODABLE
XXE5X38
Measurement of Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction, New Technology Group 8
DESCRIPTION

Determining the level of a physiological or physical function at a point in time

Part
ICD-10-PCS
X
New Technology
XX
Physiological Systems
XXE
Measurement
Source

CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.